$31.72
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Ionis Pharmaceuticals Insider Trading Activity | NASDAQ:IONS | Benzinga
Track the latest Ionis Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Ionis Pharmaceuticals stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Ionis Pharmaceuticals Inc Insiders Doing?
At Ionis Pharmaceuticals Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 140.00 shares worth $4.52K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 13, 2025, Brett P Monia, the company's CHIEF EXECUTIVE OFFICER sold 140 shares for $32.32 each.
- On February 24, 2025, Patrick R. O'Neil, the company's EVP CLO & GENERAL COUNSEL sold 1.21K shares for $32.35 each.
- On February 5, 2025, Patrick R. O'Neil, the company's EVP CLO & GENERAL COUNSEL sold 6.17K shares for $31.62 each.
Ownership Statistics for Ionis Pharmaceuticals Inc
Shares Outstanding
158.965M
Insider Shares Owned
1.495M
Insider Percentage Owned
0.94%
Institutional Shares Held
136.455M
Institutional Percentage Held
85.8%
| Mar 13, 2025 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -140.00 | $32.32 | -$4.52K | SELL | -0.08% | 180.98K | Mar 11 | View |
| Feb 24, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -1.21K | $32.35 | -$39.05K | SELL | -2.10% | 56.24K | Feb 20 | View |
| Feb 06, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -6.17K | $31.62 | -$194.94K | SELL | -9.69% | 57.45K | Feb 04 | View |
| Feb 06, 2025 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -38.84K | $31.65 | -$1.23M | SELL | -17.69% | 180.68K | Feb 04 | View |
| Feb 03, 2025 | Eric Swayze | EVP RESEARCH | 2.35K | $32.31 | -$44.16K | GRANT | 5.12% | 48.20K | Jan 30 - Jan 31 | View |
| Feb 03, 2025 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 2.55K | $32.20 | -$47.78K | GRANT | 4.35% | 61.06K | Jan 30 - Jan 31 | View |
| Feb 03, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 2.41K | $32.49 | -$45.68K | GRANT | 3.94% | 63.62K | Jan 30 - Jan 31 | View |
| Feb 03, 2025 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 12.13K | $32.45 | -$429.66K | GRANT | 5.85% | 219.53K | Jan 30 - Jan 31 | View |
| Feb 03, 2025 | Elizabeth L Hougen | EVP, FINANCE & CFO | 2.62K | $32.44 | -$49.40K | GRANT | 2.42% | 110.50K | Jan 30 - Jan 31 | View |
| Feb 03, 2025 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 2.41K | $32.40 | -$45.56K | GRANT | 2.50% | 99.08K | Jan 30 - Jan 31 | View |
| Feb 03, 2025 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 2.28K | $32.46 | -$43.08K | GRANT | 2.51% | 93.15K | Jan 30 - Jan 31 | View |
| Jan 17, 2025 | Eric Swayze | EVP RESEARCH | 11.98K | $32.84 | -$235.68K | SELL-OPTIONS | ∞ | 184.00 | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 10.85K | $32.79 | -$213.89K | SELL-OPTIONS | 22.76% | 58.51K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 12.33K | $32.83 | -$241.63K | SELL-OPTIONS | 25.23% | 61.20K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 40.00K | $32.63 | -$1.09M | SELL-OPTIONS | 23.90% | 207.40K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Elizabeth L Hougen | EVP, FINANCE & CFO | 15.02K | $32.81 | -$290.99K | SELL-OPTIONS | 16.17% | 107.89K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 11.83K | $32.86 | -$232.41K | SELL-OPTIONS | 13.94% | 96.66K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Shannon L Devers | EVP, CHIEF HUMAN RESOURCES OFC | 8.03K | $32.78 | -$139.86K | SELL-OPTIONS | 101.50% | 15.94K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | 8.88K | $32.70 | -$176.58K | SELL-OPTIONS | 19.24% | 55.05K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 11.26K | $32.90 | -$222.11K | SELL-OPTIONS | 14.14% | 90.87K | Jan 15 - Jan 16 | View |
| Jan 17, 2025 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 6.82K | $32.70 | -$144.86K | SELL-OPTIONS | ∞ | 3.07K | Jan 15 - Jan 16 | View |
| Dec 26, 2024 | Michael R Hayden | DIRECTOR | 5.00K | $36.22 | $181.08K | BUY | 15.52% | 37.22K | Dec 23 | View |
| Nov 14, 2024 | Eric Swayze | EVP RESEARCH | -1.19K | $37.92 | -$45.28K | SELL | -3.41% | 33.87K | Nov 12 | View |
| Nov 14, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -6.63K | $38.05 | -$252.29K | SELL | -3.81% | 167.39K | Nov 12 | View |
| Nov 14, 2024 | Joseph Loscalzo | DIRECTOR | -13.51K | $37.86 | -$511.43K | SELL | -29.52% | 32.25K | Nov 12 | View |
| Oct 17, 2024 | Eric Swayze | EVP RESEARCH | 72.00 | $38.31 | -$2.03K | SELL-OPTIONS | 0.21% | 35.06K | Oct 15 - Oct 16 | View |
| Sep 03, 2024 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | -651.00 | $49.40 | -$32.16K | SELL | -0.76% | 84.82K | Aug 28 - Aug 29 | View |
| Aug 06, 2024 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | -2.43K | $48.00 | -$116.64K | SELL | -2.76% | 85.51K | Aug 05 | View |
| Jul 17, 2024 | Joseph Klein III | DIRECTOR | 0.00 | $37.21 | -$306.96K | SELL-OPTIONS | 0.00% | 100.00 | Jul 16 | View |
| Jul 17, 2024 | Allene M Diaz | DIRECTOR | 3.04K | $49.49 | -$81.02K | SELL-OPTIONS | 23.98% | 15.72K | Jul 15 - Jul 16 | View |
| Jun 20, 2024 | Spencer R Berthelsen | DIRECTOR | 0.00 | $37.91 | -$76.16K | SELL-OPTIONS | 0.00% | 147.33K | Jun 17 | View |
| May 07, 2024 | Joseph Klein III | DIRECTOR | -6.00K | $42.71 | -$256.28K | SELL | -98.36% | 100.00 | May 03 | View |
| Apr 17, 2024 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 6.83K | $41.60 | -$166.64K | SELL-OPTIONS | 47.32% | 21.27K | Apr 15 - Apr 16 | View |
| Apr 17, 2024 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | 970.00 | $41.66 | -$37.70K | SELL-OPTIONS | 2.15% | 46.16K | Apr 15 - Apr 16 | View |
| Feb 16, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -387.00 | $44.49 | -$17.22K | SELL | -0.22% | 173.75K | Feb 16 | View |
| Feb 02, 2024 | Eric Swayze | EVP RESEARCH | -8.96K | $51.63 | -$654.71K | SELL | -20.67% | 34.41K | Jan 31 - Feb 02 | View |
| Feb 02, 2024 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 1.96K | $49.59 | -$102.70K | GRANT | 4.10% | 49.81K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 1.86K | $49.67 | -$97.41K | GRANT | 3.97% | 48.66K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 22.29K | $49.37 | -$1.16M | GRANT | 14.68% | 174.14K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Elizabeth L Hougen | EVP, FINANCE & CFO | 2.02K | $49.54 | -$105.27K | GRANT | 2.22% | 92.91K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 1.86K | $50.04 | -$98.13K | GRANT | 2.17% | 87.33K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | Onaiza Cadoret-Manier | EVP, CHF GL PDT STR & OPER OFC | 2.02K | $49.60 | -$105.40K | GRANT | 5.96% | 35.83K | Feb 01 - Feb 02 | View |
| Feb 02, 2024 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 1.76K | $49.52 | -$91.75K | GRANT | 2.27% | 79.08K | Feb 01 - Feb 02 | View |
| Jan 29, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -2.29K | $51.75 | -$118.25K | SELL | -1.48% | 151.85K | Jan 25 | View |
| Jan 29, 2024 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -6.45K | $51.75 | -$333.79K | SELL | -12.11% | 46.80K | Jan 25 | View |
| Jan 18, 2024 | Onaiza Cadoret-Manier | EVP, CHF GL PDT STR & OPER OFC | 9.50K | $50.42 | -$280.52K | SELL-OPTIONS | 39.07% | 33.81K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 12.90K | $50.42 | -$390.43K | SELL-OPTIONS | 31.96% | 53.25K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | 7.58K | $50.42 | -$226.73K | SELL-OPTIONS | 20.50% | 44.58K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Eric Swayze | EVP RESEARCH | 10.79K | $50.42 | -$317.88K | SELL-OPTIONS | ∞ | 85.00 | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 9.68K | $50.42 | -$276.39K | SELL-OPTIONS | 25.36% | 47.85K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 36.02K | $50.42 | -$1.62M | SELL-OPTIONS | 30.50% | 154.14K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Elizabeth L Hougen | EVP, FINANCE & CFO | 13.80K | $50.42 | -$437.77K | SELL-OPTIONS | 17.91% | 90.89K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 12.51K | $50.42 | -$369.96K | SELL-OPTIONS | 17.15% | 85.47K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 11.57K | $50.42 | -$340.06K | SELL-OPTIONS | 17.59% | 77.32K | Jan 16 - Jan 17 | View |
| Jan 18, 2024 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 3.02K | $50.42 | -$102.04K | SELL-OPTIONS | ∞ | 1.64K | Jan 16 - Jan 17 | View |
| Jan 17, 2024 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 0.00 | $43.05 | -$167.20K | SELL-OPTIONS | 0.00% | 38.17K | Jan 12 | View |
| Jan 02, 2024 | Eric Swayze | EVP RESEARCH | 0.00 | $48.76 | -$77.17K | SELL-OPTIONS | 0.00% | 32.59K | Dec 28 | View |
| Dec 28, 2023 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 0.00 | $49.40 | -$85.86K | SELL-OPTIONS | 0.00% | 40.35K | Dec 26 | View |
| Dec 28, 2023 | B. Lynne Parshall | DIRECTOR | 0.00 | $48.91 | -$369.15K | SELL-OPTIONS | 0.00% | 82.59K | Dec 26 - Dec 28 | View |
| Dec 28, 2023 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 0.00 | $49.40 | -$103.08K | SELL-OPTIONS | 0.00% | 36.05K | Dec 26 | View |
| Dec 22, 2023 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $48.36 | -$46.36K | SELL-OPTIONS | 0.00% | 65.75K | Dec 20 - Dec 21 | View |
| Dec 22, 2023 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 0.00 | $48.42 | -$22.95K | SELL-OPTIONS | 0.00% | 72.96K | Dec 20 - Dec 21 | View |
| Dec 22, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 0.00 | $48.36 | -$49.06K | SELL-OPTIONS | 0.00% | 118.11K | Dec 20 - Dec 21 | View |
| Dec 18, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 0.00 | $48.46 | -$53.86K | SELL-OPTIONS | 0.00% | 118.11K | Dec 14 | View |
| Dec 18, 2023 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 0.00 | $48.46 | -$23.82K | SELL-OPTIONS | 0.00% | 72.96K | Dec 14 | View |
| Dec 18, 2023 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $48.46 | -$50.74K | SELL-OPTIONS | 0.00% | 65.75K | Dec 14 | View |
| Nov 17, 2023 | Joseph Klein III | DIRECTOR | -2.00K | $50.00 | -$100.00K | SELL | -8.21% | 22.35K | Nov 15 | View |
| Oct 18, 2023 | Eric Swayze | EVP RESEARCH | 73.00 | $47.95 | -$2.49K | SELL-OPTIONS | 0.22% | 32.59K | Oct 16 - Oct 17 | View |
| Oct 16, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -3.77K | $46.00 | -$173.42K | SELL | -3.09% | 118.11K | Oct 12 | View |
| Sep 29, 2023 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | -4.46K | $46.50 | -$207.39K | SELL | -6.35% | 65.75K | Sep 28 | View |
| Sep 28, 2023 | B. Lynne Parshall | DIRECTOR | -10.00K | $45.13 | -$451.27K | SELL | -10.80% | 82.59K | Sep 26 | View |
| Sep 28, 2023 | Joseph Klein III | DIRECTOR | -2.00K | $45.13 | -$90.25K | SELL | -7.59% | 24.35K | Sep 26 | View |
| Aug 03, 2023 | Allene M Diaz | DIRECTOR | -657.00 | $41.05 | -$26.97K | SELL | -4.93% | 12.68K | Aug 01 | View |
| Jul 19, 2023 | Joseph Klein III | DIRECTOR | 3.56K | $42.00 | -$149.31K | SELL-OPTIONS | 15.60% | 26.35K | Jul 17 - Jul 18 | View |
| Jul 11, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -18.65K | $42.25 | -$787.95K | SELL | -13.29% | 121.72K | Jul 07 | View |
| May 24, 2023 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -1.53K | $41.70 | -$63.68K | SELL | -3.65% | 40.35K | May 24 | View |
| May 24, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -4.93K | $40.14 | -$197.91K | SELL | -3.39% | 140.37K | May 22 | View |
| Apr 19, 2023 | Brian Birchler | EVP, CORP AND DEVELOPMENT OPS | 1.20K | $36.50 | -$24.53K | SELL-OPTIONS | 3.41% | 36.53K | Apr 17 - Apr 18 | View |
| Apr 19, 2023 | Onaiza Cadoret-Manier | EVP, CHF GL PDT STR & OPER OFC | 3.08K | $36.50 | -$94.25K | SELL-OPTIONS | 14.53% | 24.31K | Apr 17 - Apr 18 | View |
| Apr 19, 2023 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 6.96K | $36.50 | -$141.63K | SELL-OPTIONS | 155.87% | 11.42K | Apr 17 - Apr 18 | View |
| Feb 07, 2023 | Eric Swayze | EVP RESEARCH | 1.90K | $40.79 | -$74.03K | GRANT | 6.32% | 31.94K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 2.62K | $40.67 | -$57.46K | GRANT | 11.74% | 24.95K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 1.90K | $40.86 | -$78.46K | GRANT | 4.79% | 41.58K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 24.44K | $40.69 | -$1.00M | GRANT | 20.22% | 145.31K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | Elizabeth L Hougen | EVP, FINANCE & CFO | 2.06K | $40.59 | -$84.39K | GRANT | 2.81% | 75.50K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 1.90K | $40.66 | -$78.07K | GRANT | 2.70% | 72.39K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | Onaiza Cadoret-Manier | EVP, CHF GL PDT STR & OPER OFC | 2.69K | $40.66 | -$59.00K | GRANT | 14.51% | 21.23K | Feb 03 - Feb 06 | View |
| Feb 07, 2023 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 1.80K | $40.57 | -$73.56K | GRANT | 2.65% | 69.65K | Feb 03 - Feb 06 | View |
| Feb 02, 2023 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -9.00K | $39.56 | -$356.07K | SELL | -18.49% | 39.68K | Jan 30 - Jan 31 | View |
| Jan 19, 2023 | Eric Swayze | EVP RESEARCH | 10.15K | $39.74 | -$223.80K | SELL-OPTIONS | 51.02% | 30.04K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Eugene Schneider | EVP, CHF CLINICAL DEVELOP OFCR | 8.29K | $39.57 | -$188.05K | SELL-OPTIONS | 59.11% | 22.33K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | 14.04K | $39.49 | -$309.48K | SELL-OPTIONS | 40.51% | 48.68K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Brett P Monia | CHIEF EXECUTIVE OFFICER | 32.20K | $39.49 | -$989.95K | SELL-OPTIONS | 36.32% | 120.86K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Elizabeth L Hougen | EVP, FINANCE & CFO | 14.87K | $39.70 | -$328.72K | SELL-OPTIONS | 25.40% | 73.44K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Richard S Geary | EVP, CHIEF DEVELOPMENT OFFICER | 14.11K | $39.57 | -$311.53K | SELL-OPTIONS | 25.03% | 70.48K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Onaiza Cadoret-Manier | EVP, CHF GL PDT STR & OPER OFC | 6.45K | $39.55 | -$148.22K | SELL-OPTIONS | 53.35% | 18.54K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | C. Frank Bennett | EVP, CHIEF SCIENTIFIC OFFICER | 12.44K | $38.89 | -$271.36K | SELL-OPTIONS | 22.45% | 67.86K | Jan 17 - Jan 18 | View |
| Jan 19, 2023 | Joseph Baroldi | EVP, CHIEF BUSINESS OFFICER | 529.00 | $39.79 | -$14.92K | SELL-OPTIONS | 13.44% | 4.46K | Jan 17 - Jan 18 | View |
| Jan 18, 2023 | Joseph Klein III | DIRECTOR | -2.00K | $40.00 | -$80.00K | SELL | -8.07% | 22.79K | Jan 17 | View |
| Sep 12, 2022 | Eric Swayze | EVP RESEARCH | -460.00 | $44.55 | -$20.49K | SELL | -2.26% | 19.89K | Sep 08 | View |
| Aug 09, 2022 | Eric Swayze | EVP RESEARCH | -1.00 | $45.20 | -$45.20 | SELL | -0.00% | 20.35K | Aug 05 | View |
| Jul 19, 2022 | Joseph Klein III | DIRECTOR | 6.67K | $38.24 | -$50.98K | SELL-OPTIONS | 36.77% | 24.79K | Jul 15 | View |
| Apr 25, 2022 | Eric Swayze | EVP RESEARCH | -378.00 | $44.15 | -$16.69K | SELL | -1.82% | 20.35K | Apr 21 | View |
| Apr 14, 2022 | Patrick R. O'Neil | EVP CLO & GENERAL COUNSEL | -6.79K | $40.06 | -$272.06K | SELL | -16.43% | 34.54K | Apr 12 | View |
| Apr 05, 2022 | Brett P Monia | CHIEF EXECUTIVE OFFICER | -355.00 | $37.49 | -$13.31K | SELL | -0.40% | 88.66K | Apr 01 | View |
| Jul 19, 2021 | Joseph Klein III | DIRECTOR | 4.33K | $35.30 | -$152.99K | SELL-OPTIONS | 31.18% | 18.23K | Jul 15 | View |
| Jun 25, 2021 | Spencer R Berthelsen | DIRECTOR | 0.00 | $23.52 | -$426.60K | SELL-OPTIONS | 0.00% | 101.05K | Jun 23 | View |
| Jun 17, 2021 | Frederick T Muto | DIRECTOR | 0.00 | $22.97 | -$410.00K | SELL-OPTIONS | 0.00% | 31.68K | Jun 15 | View |
| Mar 02, 2021 | Brett Monia | CHIEF EXECUTIVE OFFICER | 11.00 | $49.41 | -$1.81K | ACQUISITION | 0.02% | 50.11K | Feb 26 - Mar 01 | View |
| Jan 28, 2021 | STANLEY CROOKE | EXEC CHAIRMAN THE BOARD | -28.33K | $63.74 | -$1.81M | SELL | -5.40% | 496.41K | Jan 26 | View |
| Jan 27, 2021 | Patrick R. O'Neil | EVP & GENERAL COUNSEL | -5.32K | $63.50 | -$338.07K | SELL | -16.73% | 26.50K | Jan 25 | View |
| Jan 25, 2021 | STANLEY CROOKE | EXEC CHAIRMAN THE BOARD | -75.00K | $61.45 | -$4.61M | SELL | -13.10% | 497.50K | Jan 21 - Jan 22 | View |
| Jan 15, 2021 | Richard Geary | EVP, CHIEF DEVELOPMENT OFFC | -141.00 | $59.50 | -$8.39K | SELL | -0.46% | 30.31K | Jan 13 | View |
| Jan 06, 2021 | Eric Swayze | EVP, RESEARCH | -195.00 | $55.99 | -$10.92K | SELL | -3.68% | 5.11K | Jan 05 | View |
| Dec 28, 2020 | LYNNE PARSHALL | — | -10.00K | $60.00 | -$600.00K | SELL | -14.82% | 57.46K | Dec 23 | View |
| Dec 17, 2020 | STANLEY CROOKE | — | -40.41K | $49.80 | -$2.01M | SELL | -94.85% | 2.19K | Dec 15 - Dec 17 | View |
| Dec 09, 2020 | STANLEY CROOKE | — | -11.00K | $51.67 | -$568.35K | SELL | -1.69% | 640.97K | Dec 07 | View |
| Dec 08, 2020 | Brett Monia | — | 0.00 | $45.45 | -$266.29K | OPTION EXERCISE | 0.00% | 28.88K | Dec 04 | View |
| Dec 08, 2020 | FRANK BENNETT | — | 0.00 | $45.45 | -$88.77K | OPTION EXERCISE | 0.00% | 32.48K | Dec 04 | View |
| Dec 04, 2020 | FRANK BENNETT | — | 0.00 | $45.59 | -$80.76K | OPTION EXERCISE | 0.00% | 32.48K | Dec 02 | View |
| Dec 04, 2020 | Brett Monia | — | 0.00 | $45.59 | -$242.28K | OPTION EXERCISE | 0.00% | 28.88K | Dec 02 | View |
| Nov 30, 2020 | ELIZABETH HOUGEN | — | 0.00 | $44.96 | -$220.70K | OPTION EXERCISE | 0.00% | 32.49K | Nov 25 | View |
| Nov 30, 2020 | STANLEY CROOKE | — | 0.00 | $44.96 | -$132.24K | OPTION EXERCISE | 0.00% | 652.41K | Nov 25 | View |
| Nov 30, 2020 | Richard Geary | — | 0.00 | $44.96 | -$121.35K | OPTION EXERCISE | 0.00% | 30.45K | Nov 25 | View |
| Nov 30, 2020 | LYNNE PARSHALL | — | 0.00 | $44.96 | -$36.55K | OPTION EXERCISE | 0.00% | 67.46K | Nov 25 | View |
| Nov 25, 2020 | STANLEY CROOKE | — | 0.00 | $45.05 | -$152.24K | OPTION EXERCISE | 0.00% | 652.41K | Nov 23 - Nov 24 | View |
| Nov 25, 2020 | ELIZABETH HOUGEN | — | 0.00 | $45.06 | -$241.91K | OPTION EXERCISE | 0.00% | 32.49K | Nov 23 - Nov 24 | View |
| Nov 25, 2020 | Richard Geary | — | 0.00 | $45.06 | -$135.65K | OPTION EXERCISE | 0.00% | 30.45K | Nov 23 - Nov 24 | View |
| Nov 25, 2020 | LYNNE PARSHALL | — | 0.00 | $45.06 | -$40.57K | OPTION EXERCISE | 0.00% | 67.46K | Nov 23 - Nov 24 | View |
| Nov 05, 2020 | FRANK BENNETT | — | 0.00 | $43.32 | -$103.55K | OPTION EXERCISE | 0.00% | 32.48K | Nov 03 | View |
| Oct 22, 2020 | JOSEPH KLEIN III | — | -2.89K | $46.86 | -$135.39K | SELL | -17.21% | 13.89K | Oct 20 | View |
| Sep 23, 2020 | STANLEY CROOKE | — | -52.00K | $50.40 | -$2.62M | SELL | -7.38% | 652.41K | Sep 21 - Sep 22 | View |
| Sep 02, 2020 | Brett Monia | — | -78.00 | $49.08 | -$6.37K | ACQUISITION OR DISPOSITION | -0.27% | 28.88K | Aug 31 - Sep 01 | View |
| Jun 29, 2020 | Breaux Castleman | — | 0.00 | $43.33 | -$333.40K | OPTION EXERCISE | 0.00% | 15.18K | Jun 25 | View |
| Jun 29, 2020 | FRANK BENNETT | — | 0.00 | $49.82 | -$298.45K | OPTION EXERCISE | 0.00% | 32.36K | Jun 25 | View |
| Jun 26, 2020 | STANLEY CROOKE | — | -14.91K | $59.67 | -$889.91K | SELL | -2.08% | 702.41K | Jun 24 - Jun 25 | View |
| Jun 25, 2020 | SPENCER BERTHELSEN | — | 0.00 | $33.99 | -$743.10K | OPTION EXERCISE | 0.00% | 97.05K | Jun 23 | View |
| Jun 19, 2020 | STANLEY CROOKE | — | -27.00K | $58.08 | -$1.57M | SELL | -3.63% | 717.33K | Jun 17 - Jun 19 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.